520 related articles for article (PubMed ID: 31973030)
1. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
Pires-Afonso Y; Niclou SP; Michelucci A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
[No Abstract] [Full Text] [Related]
2. Elucidating tumour-associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency.
Pires-Afonso Y; Muller A; Grzyb K; Oudin A; Yabo YA; Sousa C; Scafidi A; Poli A; Cosma A; Halder R; Coowar D; Golebiewska A; Skupin A; Niclou SP; Michelucci A
Mol Oncol; 2022 Sep; 16(17):3167-3191. PubMed ID: 35838338
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated CD204
Sørensen MD; Kristensen BW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
[TBL] [Abstract][Full Text] [Related]
5. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S
Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734
[TBL] [Abstract][Full Text] [Related]
6. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
8. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
9. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies.
Morisse MC; Jouannet S; Dominguez-Villar M; Sanson M; Idbaih A
Expert Rev Neurother; 2018 Sep; 18(9):729-737. PubMed ID: 30099909
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
[TBL] [Abstract][Full Text] [Related]
11. Macrophages and microglia: the cerberus of glioblastoma.
Buonfiglioli A; Hambardzumyan D
Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
13. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
14. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
15. Immune Microenvironment in Glioblastoma Subtypes.
Chen Z; Hambardzumyan D
Front Immunol; 2018; 9():1004. PubMed ID: 29867979
[TBL] [Abstract][Full Text] [Related]
16. Microglia in Cancer: For Good or for Bad?
da Fonseca AC; Amaral R; Garcia C; Geraldo LH; Matias D; Lima FR
Adv Exp Med Biol; 2016; 949():245-261. PubMed ID: 27714693
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.
Herting CJ; Chen Z; Maximov V; Duffy A; Szulzewsky F; Shayakhmetov DM; Hambardzumyan D
Brain; 2019 Dec; 142(12):3834-3851. PubMed ID: 31665239
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466
[TBL] [Abstract][Full Text] [Related]
19. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
Zhang L; Jiang Y; Zhang G; Wei S
Front Immunol; 2023; 14():1238233. PubMed ID: 37731483
[TBL] [Abstract][Full Text] [Related]
20. Phospho-mTOR expression in human glioblastoma microglia-macrophage cells.
Lisi L; Ciotti GMP; Chiavari M; Pizzoferrato M; Mangiola A; Kalinin S; Feinstein DL; Navarra P
Neurochem Int; 2019 Oct; 129():104485. PubMed ID: 31195027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]